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SA-CME LEARNING OBJECTIVES
After completing this journal-based SA-CME
activity, participants will be able to:
 Describe the body system–specific
pathophysiology of SARS-CoV-2.
 Discuss the most appropriate imaging

modalities and radiologic recommendations for the diagnosis of nonpulmonary
multisystem manifestations of COVID-19.
 Recognize key imaging features of non-

pulmonary multisystem manifestations of
COVID-19, as well as its manifestations
in pediatric and pregnant patients.
See rsna.org/learning-center-rg.

Infection with severe acute respiratory syndrome coronavirus 2
results in coronavirus disease 2019 (COVID-19), which was declared an official pandemic by the World Health Organization on
March 11, 2020. COVID-19 has been reported in most countries,
and as of August 15, 2020, there have been over 21 million cases of
COVID-19 reported worldwide, with over 800 000 COVID-19–associated deaths. Although COVID-19 predominantly affects the
respiratory system, it has become apparent that many other organ
systems can also be involved. Imaging plays an essential role in the
diagnosis of all manifestations of the disease and its related complications, and proper utilization and interpretation of imaging examinations is crucial. A comprehensive understanding of the diagnostic
imaging hallmarks, imaging features, multisystem involvement,
and evolution of imaging findings is essential for effective patient
management and treatment. In part 1 of this article, the authors
described the viral pathogenesis, diagnostic imaging hallmarks, and
manifestations of the pulmonary and peripheral and central vascular
systems of COVID-19. In part 2 of this article, the authors focus on
the key imaging features of the varied pathologic manifestations of
COVID-19, involving the cardiac, neurologic, abdominal, dermatologic and ocular, and musculoskeletal systems, as well as the pediatric
and pregnancy-related manifestations of the virus.
Online supplemental material is available for this article.
©

RSNA, 2020 • radiographics.rsna.org

Introduction

The coronavirus disease 2019 (COVID-19) pandemic has affected every country in the world, and by August 2020 COVID-19
had infected over 21 million people (1,2). Although COVID-19 is
well known for causing respiratory pathologic findings, it can also
result in multiple extrapulmonary manifestations (3). These include
myocardial dysfunction and arrhythmia, acute coronary syndromes,
acute kidney injury, gastrointestinal symptoms, hepatocellular
injury, hyperglycemia and ketosis, neurologic illnesses, ocular
symptoms, and dermatologic complications (4). Such widespread
involvement of multiple body systems is attributable to the expression of angiotensin-converting enzyme 2 (ACE2) receptors (an
entry receptor for severe acute respiratory syndrome coronavirus
2 [SARS-CoV-2]) in multiple extrapulmonary tissues, resulting in
direct viral tissue damage. This virus is responsible for initiation of
endothelial damage and thromboinflammation and dysregulation
of immune responses, all of which contribute to the development
of extrapulmonary manifestations (4). In part 1 of this article, we
provided a detailed discussion of the pathophysiology of the virus
and its pulmonary and vascular manifestations (5).
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TEACHING POINTS
 Although COVID-19 is well known for causing respiratory

pathologic findings, it can also result in multiple extrapulmonary manifestations. These include myocardial dysfunction
and arrhythmia, acute coronary syndromes, acute kidney injury, gastrointestinal symptoms, hepatocellular injury, hyperglycemia and ketosis, neurologic illnesses, ocular symptoms,
and dermatologic complications.
 SARS-CoV-2 infection can cause detrimental effects on the

cardiovascular system and result in complications that include
myocardial injury, arrhythmia, arterial and venous thromboembolism, myocarditis, cardiomyopathy, cardiogenic shock,
and cardiac arrest.
 There is increasing evidence of neurologic manifestations as-

sociated with COVID-19, including acute stroke (6%) and altered mental status (15%). Other neurologic manifestations
include epilepsy, disturbed consciousness, encephalopathy,
and headache.
 Solid organ infarcts may also be visualized at abdominal imag-

ing in patients with COVID-19, affecting the kidney, spleen,
and liver. In a recent study of 141 patients who underwent
abdominopelvic CT, 18% had solid organ infarcts.
 According

to the American College of Radiology
Appropriateness Criteria, imaging is not indicated in a wellappearing immunocompetent child older than 3 months of
age who does not require hospitalization. However, if the
child is not responding to outpatient management or requires
hospitalization, chest radiography is considered the most appropriate first step in imaging evaluation.

In this article, we focus on extrapulmonary
imaging manifestations of COVID-19, specifically
those involving the cardiac, neurologic, abdominal, dermatologic, ocular, and musculoskeletal
systems. We also discuss pediatric manifestations
of the virus and COVID-19 in pregnant patients.
The familiarity of radiologists with the spectrum
of multisystem imaging manifestations of the virus
will ensure prompt diagnosis and thereby facilitate
appropriate care to patients and thus improve their
recovery from the infection. A thorough knowledge of the available modalities and pandemic-safe
imaging algorithms is paramount to properly manage patients with COVID-19 and optimize detection of COVID-19–related complications (Fig 1).

Cardiac Manifestations

There has been growing recognition that patients
with underlying cardiovascular disease, including
hypertension, diabetes mellitus, and obesity, may
be disproportionally affected by SARS-CoV-2
and experience a greater severity of disease, worse
prognosis, and higher risk of mortality (6,7).
SARS-CoV-2 infection can cause detrimental
effects on the cardiovascular system and result
in complications that include myocardial injury,
arrhythmia, arterial and venous thromboembolism, myocarditis, cardiomyopathy, cardiogenic
shock, and cardiac arrest (8). Myocardial injury
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occurs in 20%–30% of hospitalized patients with
COVID-19, with higher rates (55%) among those
with preexisting cardiovascular disease (6,9). Biventricular cardiomyopathy has been reported in
7%–33% of critically ill patients with COVID-19
(10), and fulminant myocarditis was suspected in
7% of patients with lethal outcome (7).
Myocardial injury, characterized by elevated
serum troponin levels, is associated with severe
disease and higher mortality and can be caused
by acute coronary syndrome, demand ischemia,
injury owing to disseminated intravascular coagulation, myocarditis, stress-induced cardiomyopathy, or cytokine release syndrome.
Several potential mechanisms of viral-induced
myocardial injury have been described. Severe
viral infection can increase the risk of plaque rupture and coronary thrombosis, resulting in myocardial infarction. Severe infection can also cause
hypoxemia and vasoconstriction and, particularly
in the setting of sepsis, lead to a decrease in
oxygen supply to the myocardium. This sustained
supply-demand mismatch can lead to myocardial
ischemia, especially in patients with underlying
atherosclerotic disease. Lastly, if disseminated
intravascular coagulation occurs in the setting of
severe sepsis, resultant systemic thrombosis can
affect the epicardial coronary arteries, as well as
the microvasculature, leading to ischemia, focal
myocardial necrosis, and severe cardiac dysfunction. Nonischemic myocardial injury can occur
in the setting of myocarditis and stress-induced
cardiomyopathy, with occurrence of acute heart
failure in those without a history of ventricular
dysfunction (11).
Imaging plays an important role in early
diagnosis of disease in patients with underlying
cardiovascular conditions, as well as detection
of cardiovascular complications in those with an
established SARS-CoV-2 infection. Although
signs of cardiac failure can be readily evaluated at
chest radiography, chest CT, and echocardiography, myocardial injury can be best assessed using
cardiac MRI.
A typical MRI protocol would include performing at least (a) short-axis cine imaging to
determine cardiac size and function, (b) T2weighted imaging, (c) delayed postcontrast (after
the administration of contrast material) imaging,
and (d) T1 and T2 mapping, if possible. Emerging evidence of the high prevalence of cardiac
involvement in patients with COVID-19 justifies
the need for performing MRI in this patient population. In fact, in a recent cohort study of 100
patients who recovered from COVID-19, cardiac
MRI helped confirm cardiac involvement in 78
patients (78%) and ongoing myocardial inflammation in 60 patients (60%). These findings were

Figure 1. Flow chart shows the suggested patient workup and role of imaging in COVID-19. Alk phos = alkaline phosphatase, c/w = consistent with, CBC diff = complete blood count with differential, CHF =
congestive heart failure, Choly = cholecystitis, Cr = creatinine, CT A/P = CT of the abdomen and pelvis, CTA = CT angiography, CXR = chest radiography, dx = diagnosis, ED = emergency department, EKG =
electrocardiography, H/N CTA = head and neck CT angiography, ICU = intensive care unit, LFT = liver function tests, MRA = MR angiography, MRV = MR venography, PE = pulmonary embolism, PCR =
polymerase chain reaction, POCUS = point-of-care US, PPE = personal protective equipment, RUQ = right upper quadrant, SOB = shortness of breath, (-) = negative, (+) = positive.
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Figure 2. Pulmonary edema in a 50-year-old woman with a history of end-stage renal disease who underwent
hemodialysis and who was admitted to the hospital for hypoxia and pneumonia in the setting of COVID-19.
(a) Upright posteroranterior chest radiograph obtained at hospital admission shows a right lower lobe consolidation (circle). (b–d) Chest radiograph (b) and axial contrast material–enhanced chest CT images (c, d)
obtained after 1 month for persistent hypoxemia show pulmonary edema (with pulmonary venous congestion
[black arrows in b] depicted on the chest radiograph), increasing small bilateral pleural effusions (arrows in c),
cardiomegaly (arrowheads in b and c), prominent interlobular septal (arrowheads in d) and peribronchovascular (arrow in d) thickening, and diffuse ground-glass opacities. The findings are indicative of pulmonary edema
superimposed on the typical appearance of COVID-19 pneumonia. Note that the right lower lobe pneumonia
depicted in a is almost completely resolved in b (white arrow in b).

independent of preexisting conditions, the severity and overall course of acute illness, and the
time from the original diagnosis (11). However,
cardiac MRI may be deferred in patients with
elevated troponin levels or suspected myocardial
injury related to myocarditis, owing to risk-benefit concerns related to infection control measures
(12). Therefore, determining an accurate diagnosis can be challenging if cardiac MRI or biopsy is
not available during the pandemic.
The development of heart failure in patients
with COVID-19 can be monitored at routine chest
radiography. Superimposed pulmonary edema in
the setting of viral pneumonia can manifest on
chest radiographs as vascular congestion, perihilar
and interstitial edema, diffuse hazy or groundglass opacities, and pleural effusions (Fig 2). At

CT, findings include interlobular septal thickening, peribronchovascular prominence, diffuse
ground-glass opacities, bilateral pleural effusions,
and cardiomegaly (Fig 2). If contrast material is
administered, the reflux of contrast material into
the inferior vena cava and hepatic veins can suggest the presence of right heart failure. On chest
radiographs and CT images, one should note
findings of atherosclerotic disease and/or signs of
prior myocardial infarction (if the patient’s history
is unavailable), including ventricular aneurysm,
myocardial thinning, and fatty metaplasia and
calcification of a post–myocardial infarction scar.
In suspected cases of myocarditis, cardiac MRI
can be performed (8). Classic MRI features of
myocarditis include regional or global wall motion abnormalities at steady-state free-precession
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Figure 3. Myocarditis in a 17-year-old adolescent boy who presented to the pediatric emergency room with chest pain and was diagnosed with elevated troponin levels,
diffuse ST-segment elevation at electrocardiography, ventricular ectopy, and COVID-19.
(a) Cardiac short-axis T2-weighted fat-saturated black-blood MR image shows diffuse
increased signal intensity in the subepicardial layer of the septal, lateral, and inferolateral
walls in the basal segment (arrows) and subepicardial layer of the lateral and inferolateral
walls of the midventricular segments (not shown), consistent with edema. (b) Precontrast
T1-weighted short-axis fat-saturated MR image shows normal myocardial thickness and
signal intensity (arrows). (c, d) Postcontrast short-axis T1-weighted cardiac MR images
obtained at the same level as b show early (c) and delayed (d) subepicardial enhancement of the basal anterior, anterolateral, inferolateral, and inferior segments in a nonischemic pattern (arrows), findings consistent with myocarditis given the clinical context. The
enhancement area corresponds to the T2 signal abnormality depicted in a.

(SSFP) cine imaging, a diffuse increase in T1 relaxation times at T1 mapping, and late gadolinium
enhancement in a nonischemic pattern, typically
with subepicardial enhancement in a nonvascular
distribution (midmyocardial and transmural enhancement is visualized less frequently). In acute
myocarditis, characteristic signal hyperintensity is
observed at black-blood T2-weighted sequences,
representing cardiac edema (Fig 3) (12,13). Myocardial edema and/or scarring have been observed
at cardiac MRI in all of the SARS-CoV-2–related
myocarditis cases for which cardiac MRI interpretation results were reported (12–14).
Cardiomyopathy is a common complication
of SARS-CoV-2 infection and may result from
myocarditis, profound systemic inflammation, and/
or microvascular dysfunction. A case series study
showed that 67% of critically ill patients with COVID-19 required treatment with vasopressor medication and that 33% developed cardiomyopathy
(15). It is important to note that cardiomyopathy
can occur with mild or absent respiratory symptoms. Chest radiographs may show cardiomegaly
and signs of acute congestive failure, which manifest with cephalization of pulmonary vessels, pleural effusion, and Kerley B lines (Fig 2). Cardiac
CT or MRI may show dilated ventricles, decreased
ejection fraction, and MRI signs of myocarditis (as
discussed previously) (Movie 1). (16).
Cardiomyopathy and myocarditis in severe or
critically ill COVID-19 cases could contribute to

the development of cardiac arrhythmias, including
atrial fibrillation. Atrial fibrillation was a cause of
fatality in 6.8% of patients with COVID-19 in Italy (17). The hypercoagulable state associated with
COVID-19 also significantly contributes to the
development of central vascular thrombosis (5).
Attention to the cardiac chambers and appendages, as well as the thoracic aorta, should be made
at CT angiography to avoid missing a cardiac
thrombosis and potential source of embolism in
abdominal vasculature, peripheral arterial vessels,
and elsewhere (Fig 4, E1).

Neurologic Manifestations

There is increasing evidence of neurologic manifestations associated with COVID-19, including acute stroke (6%) and altered mental status
(15%) (18). Other neurologic manifestations
include epilepsy, disturbed consciousness, encephalopathy, and headache (19). Various pathophysiologic mechanisms of neurologic sequelae
have been proposed, including injury to the
vascular endothelial and epithelial cells, resulting
in disruption of the blood brain barrier; hypoxic
injury owing to respiratory failure (acute respiratory distress syndrome [ARDS]) and prolonged
ventilation; ACE2 receptor–facilitated entry of
the virus into neural tissue cells; and immune
injury secondary to cytokine storm syndrome
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Figure 4. Right ventricular thrombus and COVID-19
pneumonia in a 62-year-old man with hypoxia and
markedly elevated d-dimer levels (>50 000 ng/mL). Axial chest CT angiographic image shows a well-circumscribed hypoattenuating filling defect within the lumen
of the right ventricle, indicative of a thrombus (solid arrow). Patchy lung opacities (dashed arrows) related to
COVID-19 pneumonia are only vaguely depicted, owing to the window settings used.

(19–21). In fact, the neurotropism of coronavirus may indeed be responsible for the relatively
high percentage of neurologic involvement in this
group (22,23). In addition, SARS-CoV-2–induced coagulopathy significantly contributes to
the development of neurologic manifestations in
patients with COVID-19 (18,19,24).
Patients with COVID-19 who present with
neurologic or psychiatric symptoms may undergo
nonenhanced CT of the head to identify potential vascular complications such as stroke, hemorrhage, or venous sinus thrombosis. In the setting
of a suspected infarct, nonenhanced MRI of the
brain can be performed for definitive assessment.
Abbreviated MRI protocols can be adopted in
this setting, limited to the acquisition of critical
sequences such as diffusion-weighted imaging
and corresponding apparent diffusion coefficient
(ADC) mapping, as well as axial T2-weighted
fluid-attenuated inversion-recovery (FLAIR)
sequences. The use of contrast material can be
helpful in imaging patients with suspected viral
encephalitis to assess for potential leptomeningeal enhancement.
About one-third of patients with acute or
subacute COVID-19 referred for neuroimaging
may show brain abnormalities (25). The results of
a large multi-institutional study in France showed
ischemic strokes depicted in 27% of patients,
leptomeningeal enhancement in 17%, and encephalitis in 13% (26). Large infarcts have been
reported in 45% of patients, with lacunar infarcts
in 24% and hemorrhagic stroke in another 24%
of 38 patients with COVID-19 from a large cohort within the New York health system (27).
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A wide spectrum of imaging findings has been
described in patients with COVID-19. The results of a recent study with a large nationwide cohort revealed the most common imaging finding
to be unilateral FLAIR and/or diffusion hyperintensities in the mesial temporal lobe (depicted in
43%) (28). These may be due to infectious versus
autoimmune encephalitis. Nonconfluent multifocal white matter hyperintense lesions associated
with hemorrhagic lesions have been reported in
30%, in a pattern similar to that in acute disseminated encephalomyelitis or acute hemorrhagic
leukoencephalitis (28,29). Extensive and isolated
white matter microhemorrhages were depicted in
up to 24%, in a pattern reminiscent of disseminated intravascular coagulation (28,30).
Patients may have extensive and confluent
supratentorial white matter hyperintensities at
FLAIR imaging or nonconfluent multifocal white
matter FLAIR hyperintense lesions. T2-hyperintense lesions have also been reported uncommonly in the splenium of the corpus callosum
and in the bilateral middle cerebellar peduncles
(28). The potential explanation for white matter hyperintense lesions may include viral encephalitis, postinfectious demyelination, delayed
posthypoxic leukoencephalopathy, metabolic or
toxic encephalopathy, or posterior reversible encephalopathy syndrome (28–31). Acute necrotizing encephalopathy may be found uncommonly,
with hemorrhagic rim-enhancing lesions within
the bilateral thalami, medial temporal lobes, and
subinsular regions (32). Up to 25% of patients
may have a combination of two or more imaging
patterns (28).
There are multiple reports that describe other
neurologic manifestations such as sudden loss of
taste (hypogeusia) or smell (hyposmia, anosmia),
implying that the viral central nervous system
invasion in COVID-19 is possible through a
retrograde neuronal route, with direct damage to
the olfactory and gustatory receptors (33,34).
Assessment of the main intracranial vessels for
hyperattenuation (eg, hyperattenuating middle
cerebral artery sign) at nonenhanced CT is essential for the diagnosis of a large vessel occlusion. Embolic infarcts depicted as multiple areas
of hypoattenuation in the white matter–gray
matter junction can be identified and are reflective of thromboembolization, specifically cardiothromboembolism or arterio-arterial embolization (Figs 5, 6) (35). Watershed infarcts between
arterial territories can be found in patients with
hypoperfusion (Fig 7). Posterior reversible encephalopathy syndrome should be suspected with
signal intensity changes seen at MRI or areas
of hypoattenuation seen at CT in the parietooccipital white matter, especially in a setting of
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Figure 5. Long segment right internal carotid artery (ICA) occlusion with associated bilateral large
middle cerebral artery territory infarcts in a 59-yearold man who underwent intubation due to COVID-19
who presented with sudden onset of confusion. The
serum analysis results showed a high d-dimer level of
5.6 mg/mL. (a) Axial nonenhanced head CT image
shows large regions of hypoattenuation (arrows) in
the bilateral middle cerebral artery territories, reflecting cytotoxic edema secondary to acute bilateral
middle cerebral artery territorial infarctions without
hemorrhagic transformation. The findings are indicative of cardioembolic phenomena (given various vascular distributions), hypoxic-ischemic injury,
or ischemic vasculopathy secondary to COVID-19.
(b–d) Sagittal maximum intensity projection (b) and
axial head and neck CT angiographic images (c, d)
show a long segment filling defect from the proximal cervical segment of the right ICA (arrow in b)
to the intracranial ICA, with involvement of the right
petrous (not shown) and cavernous ICA segments
(arrow in c), indicative of right ICA thrombosis and
occlusion. The right carotid terminus (white arrow
in d) and right middle cerebral artery are completely
occluded, and the M1 segment of the left middle cerebral artery is nearly completely occluded, with only
a small sleeve of intravenous contrast material opacifying the artery (black arrow in d). Note that the loss
of gray matter–white matter differentiation is more
pronounced on the right (arrowheads in d).

Figure 6. Multiple brain infarcts in various vascular territories and intraparenchymal hemorrhage after extubation in a 58-year-old woman with a history of diabetes mellitus who was hospitalized with COVID-19. The
patient’s hospital stay was complicated by multiorgan failure, line sepsis, and new neurologic deficits. (a) Axial
T2-weighted (T2) FLAIR brain MR image shows a focal heterogeneous hyperintensity (arrow) within the right
occipital lobe, representing an evolving intraparenchymal hematoma, with surrounding edema and mass effect.
(b, c) Axial diffusion-weighted (DWI) and ADC MR images show restricted diffusion in the right frontal lobe,
compatible with a small focus of acute infarct (arrow). Additional foci of restricted diffusion were depicted in the
left frontal lobe (not shown), consistent with small infarcts in different vascular distributions.

hypertension. Sinus thrombosis can be visualized
at nonenhanced head CT as a linear hyperattenuation within a sinus or large cortical vein and, if
necessary, can be confirmed at CT venography

or MR venography, at which filling defects will be
depicted in the venous sinuses (Fig 8).
Venous infarcts should be suspected when
they are bilateral, depicted in nonarterial ter-
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Figure 7. Watershed infarcts and cardioembolic infarcts in a 55-year-old woman with COVID-19 who presented with left gaze deviation. (a) Initial axial T2-weighted (T2) FLAIR brain MR image shows hyperintense
signal abnormality (arrows), predominantly within the high frontal and parietal subcortical white matter
bilaterally. (b) Repeat axial T2-weighted (T2) FLAIR MR image obtained 3 days later shows interval development of a linearly oriented pattern of signal abnormality (arrows) within the centrum semiovale bilaterally,
greater on the left than on the right. (c, d) Axial diffusion-weighted (DWI) (c) and ADC (d) brain MR images
show restricted diffusion in the corresponding areas of abnormality (arrows), indicative of watershed infarcts.
(e, f) Axial diffusion-weighted (DWI) (e) and ADC (f) brain MR images show restricted diffusion involving the
bilateral occipital lobes (arrows), indicative of additional foci of acute infarct.

ritory, and in the presence of hemorrhage (Fig
8). Hyperintense signal with T2-weighted and
T2-weighted FLAIR sequences in association
with restricted diffusion at diffusion-weighted
imaging have been described in encephalopathy
and encephalitis, especially in the inferomedial
regions of the temporal lobes or insular cortex (Fig 9). Similar findings can be found with
hemorrhagic diffuse leukoencephalopathy (Fig
10). Patients with COVID-19 are commonly
administered anticoagulation therapy, which
can become complicated by the development of
spontaneous or traumatic intracranial hemorrhage (Fig 11).

Abdominal Manifestations

Although patients typically present with respiratory illness, up to 40% of patients with COVID-19 present with digestive symptoms, which
include diarrhea, vomiting, and acute abdominal
pain (36–38). Additionally, patients with CO-

VID-19 commonly develop elevated liver enzymes and biliary stasis (39). The coronavirus
RNA was readily detected in stool specimens of
patients with SARS-CoV-2 infection, and the
results of electron microscopy of biopsy and autopsy specimens confirmed active viral replication
in both the small and large intestines (40–42).
SARS-CoV-2 tropism to the gastrointestinal tract
is likely due to its abundant expression of ACE2
receptors, specifically in the esophagus, stomach,
duodenum, small and large intestine (including
the rectum), and biliary endothelium (43).
US has served as a primary imaging modality
for patients with abdominal and pelvic symptoms
during this pandemic. Right upper quadrant and
abdominal Doppler US are employed in patients
with elevated liver function enzyme levels for the
assessment of liver disease, gallbladder disease,
biliary stasis, and portal vein thrombosis. Renal
US can be performed if there is concern for renal
obstruction in the setting of elevated creatinine
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Figure 8. Hemorrhagic venous infarct related to venous thrombosis in a 29-year-old woman who had two seizures after
having 1 week of cough and fever and who received positive test results for COVID-19 in the emergency department. (a) Axial
nonenhanced head CT image shows a left temporoparietal hemorrhagic venous infarct (arrows), with adjacent edema, mass
effect, and minimal rightward midline shift. (b) Axial CT venogram shows absence of contrast material in the left sigmoid
sinus (arrows), indicative of venous sinus thrombosis. (c) Three-dimensional maximum intensity projection image from MR
venography shows thrombosis of the left transverse and sigmoid sinuses (solid arrows). Note that the right transverse sinus
appears patent (dashed arrow).

Figure 9. Viral encephalitis in a 57-year-old man with a history of hypoxemic
respiratory failure who required intubation in the setting of COVID-19 pneumonia.
The hospital stay was complicated by hypercoagulability in the setting of COVID-19.
(a, b) Axial (a) and coronal (b) T2-weighted (T2) FLAIR MR images show an infiltrative pattern of heterogeneous signal abnormality (arrows) throughout the left
cerebral hemisphere involving the frontal, temporal, and occipital lobes, as well as
the basal ganglia and thalamus. (c) Axial susceptibility-weighted image (SWI) shows
multiple nodular and curvilinear foci of abnormal magnetic susceptibility (arrows),
consistent with foci of parenchymal and subarachnoid hemorrhage. (d) Axial postcontrast T1-weighted MR image shows an amorphous curvilinear pattern of avid
contrast enhancement (arrows).

levels and decreased urine output, and renal Doppler US may also detect renal infarction.
Doppler US can be performed in patients with
suspected abdominal venous or arterial thrombosis. During the COVID-19 pandemic, there
has been a significant increase in the utilization
of point-of-care US by radiologists, as well as
in emergency departments, medical wards, and
intensive care units. In addition to evaluation of
respiratory abnormalities, point-of-care US has
been shown to be helpful in monitoring levels of
dehydration through the assessment of the inferior vena cava, pericardial and pleural effusions,

hydronephrosis, intravenous line placement, and
more (44).
Multiple institutions have developed customized abbreviated US protocols in an attempt to
minimize sonographer exposure to virus particles
while performing US examinations in patients
with COVID-19. These protocols have been
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Figure 10. Hemorrhagic diffuse leukoencephalopathy in a 43-year-old woman with COVID-19.
The hospital stay was complicated by inability
to follow commands and persistently depressed
status after extubation. The laboratory test results showed markedly elevated d-dimer levels
(>7.6 mg/mL), international normalized ratio
level (1.4), and platelet count (290). (a) Axial
T2-weighted MR image shows confluent bilateral
signal hyperintensities (arrows) in the white matter of both parietal lobes. No associated diffusion
restriction was depicted on diffusion-weighted or
ADC images (not shown). (b) Axial gradient-echo
MR image shows punctate microhemorrhages
(arrow) in the subcortical white matter of the left
occipital lobe. Multiple microhemorrhages were
scattered throughout the cerebral hemispheres
bilaterally and in the splenium of the corpus callosum (not shown).

Figure 11.
Intraventricular hemorrhage in a 65-yearold man receiving anticoagulation therapy in the intensive care unit as treatment
for severe COVID-19 pneumonia. Axial nonenhanced
CT image of the head shows
a small amount of layering
hyperattenuating fluid in
the bilateral atria of the lateral ventricles, compatible
with either spontaneous or
traumatic acute intraventricular hemorrhage.

designed to focus on obtaining essential images
to answer a pertinent clinical question. It has also
been recommended to obtain cine clips of critical
structures rather than multiple static images to
minimize the time of scanning and the need for
repeat examinations (45). Similarly, to decrease
imaging time, some institutions have implemented postprocessing and image labeling after
the examination.
Patients presenting to the emergency department with nonspecific gastrointestinal symptoms
such as abdominal pain may undergo abdominopelvic CT when a COVID-19 diagnosis is not
the primary consideration (46). The presence of
bilateral ground-glass opacities at the lung bases
should raise concern for COVID-19, and appropriate disinfectant and preventative measures
should be followed for cleaning the equipment
and alerting personnel. In the nonemergent
setting, CT of the abdomen and pelvis with
intravenous contrast material can be performed
in patients with COVID-19 in whom abdominal complications such as bowel ischemia and
perforation, solid organ injury or infarct, and

cholestasis-related complications are suspected.
Generally, CT images are obtained in the portal
venous phase. However, CT angiography and venography can be performed in cases of suspected
abdominal vascular thrombosis.
A recent preliminary observational study
performed in 412 patients with 224 abdominal
imaging examinations showed that bowel abnormalities and cholestasis were common findings at
abdominal imaging (47). In this study, the most
common indications for performing right upper
quadrant US were elevated liver function enzyme
levels and to evaluate for a source of infection. The
common indications for CT were abdominal pain
and to evaluate for a source of infection. Nausea,
vomiting, diarrhea, and suspected bowel ischemia
were less common indications (47). It is important
to note that some patients with COVID-19 who
initially presented with symptoms of abdominal pain did not have any detectable abdominal
findings, and it is thought that their symptoms
were attributable to referred pain. This is a similar
phenomenon to that seen in other basilar pneumonias (particularly disease located near the pleura
or diaphragm) caused by multiple organisms (eg,
Legionella, Mycoplasma species) and has been reported in children as well as in adults (46).

Intestinal Manifestations

Intestinal involvement related to COVID-19 can
be in the form of gastritis, enteritis, colitis, or a
combination of two or all entities. They result from
either direct viral infection, virus-induced bowel
inflammation, or bowel wall ischemia. In patients
with COVID-19, bowel wall ischemia occurs in the
setting of either arterial macro- or microthrombosis
or venous occlusion and mesenteric congestion and
inflammation. As it was noticed with other types of
coronaviruses, there have been multiple reported
cases of enterocolitis and bowel ischemia in adult
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Figure 12. Gastritis and colitis in two patients
who each presented with epigastric and abdominal pain and received positive test results for COVID-19 in the emergency department. Coronal
contrast-enhanced CT images of the abdomen
and pelvis show thickening of the gastric wall
and associated mucosal hyperenhancement (arrows in a) and thickening of the ascending and
descending colon with mucosal enhancement
(arrows in b), findings that are indicative of gastritis (a) and colitis (b), respectively. Note the
hepatic steatosis in a.

Figure 13. Proctocolitis in a 72-year-old man who presented to the emergency
department with abdominal pain and fever and was diagnosed with COVID-19.
Sagittal (a) and axial (b) contrast-enhanced CT images of the abdomen and pelvis
show marked edema of the distended rectal wall (white arrows), with hyperenhancing mucosa (black arrow) and significant inflammatory changes in the surrounding
perirectal fat (*). Note that the remaining large bowel wall is normal (arrowhead
in a), and no significant amount of stool is depicted in the rectum. On the day of
hospital admission, CT images of the abdomen and pelvis obtained through the
lung bases depicted bilateral peripheral airspace opacities, ground-glass opacities,
and areas of consolidations (not shown), findings typical of COVID-19 pneumonia.

patients with COVID-19 and hemorrhagic enterocolitis and necrotizing enterocolitis in infants with
coronavirus infection (48–50).
Abdominal and pelvic CT findings of viral gastritis and/or enterocolitis that have been described
in COVID-19 include wall thickening and edema
(29% of patients), with predominant colorectal
and small bowel involvement, fluid-filled mildly
distended intestinal lumen (43% of patients), and
mucosal hyperenhancement (Figs 12, 13) (47).
Thickening of the bowel wall is usually attributable to submucosal edema and edema of the bowel
folds, resulting in an accordion sign, similar to
those findings seen in other forms of viral enteritis (51). In some cases, bowel wall thickening can
resemble graft-versus-host disease at imaging,
with areas of narrowing and dilatation, mucosal
hyperenhancement, and ribbonlike or featureless
appearance of the wall owing to bowel folds edema
(Fig E2). Inflammatory changes in the surrounding
fat also commonly manifest and are thought to be
attributable to COVID-19–related immunoreaction and cytokine production (50,52).
Dependent on the severity and acuity of vascular compromise, COVID-19–related bowel ischemia can be divided into early, intermediate, and
late presentations. The causes of bowel ischemia
may not always be identified at imaging. However,
taking into account that there is a strong association between COVID-19 and vascular coagulopa-

thy, thromboembolic disease within the mesenteric
vasculature is a common cause of acute mesenteric
(bowel) ischemia in this patient population (5,53).
A vigilant and systematic approach is needed to
suspect, diagnose, and manage this otherwise fatal
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Figure 14. Superior mesenteric artery thrombosis complicated by bowel ischemia and perforation in a 54-year-old man
who presented to the emergency department with abdominal pain and was diagnosed with COVID-19. (a–c) Coronal (a)
and axial (b, c) contrast-enhanced CT images of the abdomen and pelvis show mucosal hyperenhancement involving the
small bowel (F in a, white arrow in c), with associated mild wall thickening. There is a long segment of bowel wall hypoenhancement in the distal ileum, with a large focal wall defect (solid white arrows in a). Note the extension of intraluminal
bowel contents, fluid, and air through the defect into the peritoneum (dashed arrow in a). The findings are indicative of
bowel ischemia with distal ileal bowel wall perforation. There are multiple fluid-filled dilated loops of small bowel proximal
to this region, suggestive of an ileus. There are associated thrombi within the proximal superior mesenteric artery (black
arrow in a, arrow in b) and in the distal ileal branches (not shown). Mesenteric congestion and trace ascites are noted (*
in a and c). However, no organized fluid collection is depicted. Note the enlarged nonenhancing left external iliac vein,
compatible with deep vein thrombosis (black arrow in c). (d) Gray-scale (left) and power Doppler (right) US images of the
left upper extremity, obtained owing to arm swelling, show a near-occlusive thrombus extending from the forearm to the
upper humeral segment of the cephalic vein (Ceph V) (arrows in d).

complication of severe COVID-19 (53). Therefore,
the mesenteric vasculature should be carefully
assessed for possible arterial or venous thrombosis involving the main arterial and venous blood
supply to the bowel, including the superior and
inferior mesenteric arteries and veins and portal
vein (Fig 14, E3).
Mesenteric thrombus can be readily visualized
at CT angiography and in some cases in the portal venous phase as a filling defect in the lumen,
either at the more proximal aspect of the artery,
extending from the aorta, or more distally (Fig
14, E3). Thick-walled, edematous, fluid-filled,
and dilated bowel (in some cases >3 cm) should
raise suspicion for acute mesenteric ischemia at

CT (53), and nonenhancing thickened bowel
suggests bowel infarction. On CT images, the
early phase of bowel ischemia may only show
contracted gasless bowel that, when progressed,
may transform into dilated gas-filled bowel with
a paper-thin bowel wall. The CT findings of the
later phase of ischemia include the development
of intestinal wall pneumatosis, absence of mucosal enhancement, and luminal dilatation (Figs 14,
15, E4). Portal venous and mesenteric gas may
also be apparent. Bowel infarction can result in
frank bowel wall perforation, which would be visualized at imaging as discontinuity of the bowel
wall, with an associated localized collection of air
and/or adjacent fluid collection and/or abscess
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Figure 15.
Bowel ischemia
and perforation as a complication of COVID-19 in a 65-yearold man with a history of
asthma, hypertension, and hyperlipidemia. (a–c) Axial (a, c)
and coronal (b, d) intravenous
contrast material–enhanced CT
images of the abdomen and
pelvis show significant pneumatosis of the cecum and right ascending colon (dashed arrows
in a and d), with associated
perforation of the ascending
colon (AC and dashed arrows in
b) and a large complex fluid collection with an enhancing rim,
indicative of an abscess (solid
arrows in b). The abscess is filled
with extravasated fecal material.
Note the mesenteric venous
gas (solid arrows in a), associated with pneumatosis. Note
also the small amount of ascites
and mesenteric congestion (*
in a and d). Portal venous gas
is present (solid arrows in c and
d). Peripheral airspace disease
(black arrow in d) in the right
lower lobe is also depicted.

(Figs 14, 15). Presence of either the cupola or
saddlebag sign, Rigler sign, and/or lucent liver
sign are indicative of pneumoperitoneum (54).
Although evidence of mesenteric congestion
and hyperemia may be signs of microthrombosis, microthrombosis of the vascular beds of the
pericolonic mesentery and submucosal arterioles
of the bowel wall, which have been described in
pathology reports from autopsy in patients who
died from COVID-19, cannot usually be detected
at imaging (47). Bowel infarction can be accompanied by denudation of the epithelium, which
can be seen on direct visualization of the intestinal lumen (Fig 16, E4).
Hemorrhagic transformation may also be apparent at CT, characterized by the presence of
hyperattenuating material within the lumen of the
affected bowel. Pneumatosis and portal venous
gas were identified in 20% of CT examinations
performed in patients with COVID-19 in the
intensive care unit (47). Pneumatosis and portal
gas may also be readily detected on abdominal
radiographs and US images and if found should
prompt a search for the causes and location of
bowel ischemia (Fig 15). However, the presence
of pneumatosis must be interpreted with caution, as it may manifest secondary to mechanical
ventilation in patients with severe COVID-19 or

may represent an extension of air in the thorax
(pneumothorax, pneumopericardium, or pneumomediastinum) (Fig 17) (53).

Abdominal Solid Organ
Manifestations
Liver and Biliary Manifestations
The liver is the most frequently damaged organ
outside of those of the respiratory system in COVID-19. The mechanism of hepatic injury is not
fully understood, although it is most likely multifactorial and attributable to direct viral infection
that results in damage to cholangiocytes, immunerelated injury, and/or drug hepatotoxicity (55,56).
A substantial proportion of patients with severe
acute respiratory syndrome (SARS) and patients
with COVID-19 demonstrate variable degrees
of liver damage (57). The ACE2 receptor has
been found to be expressed in the liver, specifically in cholangiocytes (epithelial cells of the bile
ducts) rather than in hepatocytes, and this may be
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Figure 16. Ischemic enterocolitis, periportal edema, mesenteric congestion, ascites, and multifocal bilateral native and renal
transplant infarcts in a severely ill 75-year-old man with COVID-19 pneumonia, elevated liver function test results, and oliguria.
(a, b) Coronal (a) and axial (b) contrast-enhanced images of the abdomen and pelvis show marked pericholecystic and periportal edema (white arrows) and thickened small and large bowel (black arrows). Note that the colon is fluid filled. Multifocal
wedge-shaped areas of hypoattenuation are depicted in the renal cortex of the transplant kidney allograft and native kidneys
(arrowheads), compatible with multifocal native renal and renal transplant infarcts. Note the marked heterogeneity of the liver parenchyma that could be attributable to hepatitis (* in a). The main mesenteric vasculature was patent. Mesenteric congestion and
ascites were also present, implying the manifestation of mesenteric ischemia, likely as a result of microthrombosis. (c) Endoscopic
image of the left colon shows denudation of the colonic epithelium, compatible with ischemic colitis. (Case courtesy of Christine
[Cooky] Menias, MD, Mayo Clinic, Phoenix, Ariz.)

responsible for liver damage in COVID-19 (57).
Researchers have found that viral infection with
SARS-CoV-2 impairs the barrier and bile acid
transport functions of cholangiocytes through
dysregulation of genes involved in tight junction
formation and bile acid transportation. This could
explain the accumulation of bile acids and resultant liver damage in patients (58).
Liver injury manifests as elevation of hepatic
enzyme levels. Current data show that 14.8%–
53% of patients with COVID-19 have abnormal
levels of alanine aminotransferase and aspartate
aminotransferase during the course of disease
and mild elevation in serum bilirubin levels
(37,59–62). Also, approximately 50% of patients
with COVID-19 had increased levels of γ-glutamyl
transferase (GGT) (39). In the published literature
to date, hepatic manifestations of COVID-19 were
mostly mild and transient, although severe liver
damage may occur. The proportion of liver injury
was also higher in patients with severe COVID-19
(63). Periportal necrosis, lymphocytic infiltration
of the sinusoids, dense portal infiltration by abnormally small lymphocytes, central vein thrombosis,
and cirrhotic changes with thick fibrosis were all
findings at liver autopsy (64,65).
Another potential cause of liver damage and
elevated liver enzyme levels is microthrombosis
within hepatic sinusoids, which likely is related to
previously described generalized coagulopathy, as
well as liver-induced coagulopathy (59). Hypoxic
or ischemic hepatic injury, resulting from either a
coagulopathy-induced decrease in hepatic perfu-

sion or a respiratory-induced hypoxia, may also
result in high serum aminotransferase concentrations (66).
Although US, CT, and MRI are all excellent
modalities for the evaluation of hepatic and biliary
disease, the imaging findings in COVID-19 may
not be pathogen-specific, and findings are commonly nonspecific and subtle. At cross-sectional
imaging, periportal edema and heterogeneity of
the liver parenchyma should raise concern for
hepatitis (Fig 16). Periportal edema may be more
apparent at both CT and MRI (Fig 16). There has
also been increased prevalence of hepatic steatosis
in patients with COVID-19 that is likely attributable to the known association between infection
and obesity (64). In fact, it has been reported that
hepatic steatosis is an independent risk factor of
severe disease (67).
Biliary stasis may be diagnosed by recognition of gallbladder and intrahepatic biliary ductal
dilatation, without a causative obstructive mass or
stone. Sludge and stones within a dilated gallbladder, reflective of cholestasis, were detected in 54%
of patients with COVID-19, and it is important to
note that acute cholecystitis can develop as a result
of biliary stasis (Figs 18, 19) (47). In comparison,
the incidence for the development of gallstones in
the general population is about 10%–20% (68).
Complications related to micro- and macrothrombosis may not be readily apparent at Doppler US, contrast-enhanced CT, or MRI. Echogenic mobile foci detected at gray-scale US within
the portal vein and its branches, extending to the
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Figure 17. Pneumopericardium with air dissecting into the peritoneum, mimicking bowel perforation, in a
64-year-old man who underwent intubation for COVID-19 pneumonia. (a) Axial nonenhanced chest CT image
shows pneumopericardium (black arrows) and bibasilar airspace consolidations (white arrows), compatible with
COVID-19 pneumonia. (b) Axial nonenhanced CT image of the abdomen and pelvis shows pneumopericardium
and free air under the diaphragm, anterior to the liver (black arrows), without findings of bowel wall ischemia to
suggest a perforation (not shown). Note the bibasilar consolidations (white arrows).

periphery of the liver, is indicative of portal venous
gas, which implies the presence of bowel ischemia.
Gas in the portal system can be confirmed by the
visualization of specific spikes corresponding to air
bubbles at spectral Doppler US interrogation of
the portal vein.
As discussed previously, the bowel should be
evaluated for possible evidence of bowel ischemia
and/or perforation by using CT or less commonly
US, and the mesenteric vasculature should be assessed for patency. Absent flow at color or spectral
Doppler US in one of the hepatic vascular systems
should raise suspicion for hepatic vascular thrombosis, which may affect the hepatic veins (central
and/or peripheral branches), the intrahepatic
inferior vena cava, and/or the portal vein (Fig E5)
(69–72). It is important to note that other venous
thromboses, such as those involving the renal,
ovarian, or deep pelvic veins, may also be depicted
(Fig 20) (73,74). Dependent on the acuity of the
thrombosis, a clot may or may not be visualized at
gray-scale US, and the affected vein may appear
distended by the blood clot. The corresponding
finding of a filling defect may be observed within
the affected vessel at contrast-enhanced CT and
gadolinium-enhanced MRI (Figs 20, E5).

Vascular Complications of Solid Organs
Solid organ infarcts may also be visualized at
abdominal imaging in patients with COVID-19,
affecting the kidney, spleen, and liver (47) (Figs
16, 18, 21–23). In a recent study of 141 patients
who underwent abdominopelvic CT, 18% had
solid organ infarcts (75). At Doppler US, decreased vascularity may be depicted within a solid
organ, indicative of an infarct, and in these cases it

is essential to assess the primary vasculature of the
affected organ for the presence of a blood clot (Fig
22). Contrast-enhanced CT images may show a
hypoattenuated wedge-shaped area in the solid
organ parenchyma, corresponding to the infarct.
Vascular thrombosis may be seen as a filling defect
within one or more of the supplying vessels at CT
and US (Fig E5).

Pancreas
Pancreatic injury has been described in COVID-19 and is thought to be a result of either
direct or indirect mechanisms. The direct mechanism stems from a cytopathic effect mediated
by local viral replication (pancreatic islet and
exocrine gland cells have abundant ACE2 receptors), whereas the indirect mechanism pertains to
either a systemic response to respiratory failure
or a harmful immune response induced by the
virus itself (76,77). Wang et al (77) found that
17% of patients with diagnosed COVID-19 had
pancreatic injury. Direct injury to the islet cells
can result in acute diabetes (78). Pancreatitis can
either be confirmed by laboratory data (elevated
lipase and amylase levels) or can be diagnosed
at imaging (77). Changes within the pancreatic
parenchyma, such as hypoechogenicity and heterogeneity at US or hypoattenuation and lack of
enhancement at CT, with associated peri-pancreatic inflammatory changes, should raise concern
for pancreatitis (Fig 24).

Urogenital Tract
Acute kidney injury is commonly encountered
among critically ill patients with COVID-19,
affecting approximately 20%–40% of patients ad-
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Figure 18. Heterogeneous liver enhancement and biliary stasis in an 84-year-old woman with a history
of hypertension and asthma who was admitted to the intensive care unit for hypoxic respiratory failure
secondary to COVID-19 pneumonia and septic shock. The results of a laboratory test also confirmed elevated transaminase levels (aspartate transaminase, 1085 U/L; alanine transaminase, 741 U/L). The patient
died 3 days later despite cholecystostomy placement. Axial (a) and coronal (b) CT angiographic images
of the abdomen and pelvis show marked heterogeneous enhancement within the liver, with multiple
areas of hypoenhancement along the biliary distribution (arrows in a). The gallbladder (GB) is distended,
and there is a marked dilatation of the extrahepatic biliary duct (black arrow in b), with gradual tapering
of the common bile duct within its distal segment (white arrow in b). No radiopaque obstructive stones
or sludge were visualized. The findings are indicative of biliary stasis and an infectious or inflammatory
process of the gallbladder. Note that the sensitivity of gallstone evaluation at CT is variable based on the
composition of the stones.

Figure 19. Acute cholecystitis in
a critically ill 64-year-old man with
COVID-19 and sepsis. Gray-scale (a)
and color Doppler (b) US images
show a dilated gallbladder (GB)
with sludge (* in b). Significant
wall edema (dashed arrow) and
hyperemia (solid arrows in b)
are also present. The US Murphy
sign was not assessed owing to
the patient’s altered mental status. The findings are indicative of
bile stasis and acute cholecystitis.
Sterile green thick dark bile was
visualized during cholecystostomy
placement.

mitted to the hospital and particularly to the intensive care unit in Europe and the United States
(79,80). Acute kidney injury occurred at much
higher rates in critically ill patients admitted to
New York City hospitals, ranging from 78% to
90% (79,81–84). Approximately 20%–31% of
patients admitted to the intensive care unit require renal replacement therapy (80,85,86).
There is emerging evidence of a distinct pathophysiologic mechanism of SARS-CoV-2–mediated
acute kidney injury (83,87,88), which manifests
clinically and pathologically by the development
of acute tubular necrosis, interstitial inflammation,
podocytopathy, microangiopathy, and collapsing
glomerulopathy (87). US may show increased
cortical echogenicity or heterogeneity and loss of

corticomedullary differentiation in patients with
COVID-19 and acute kidney injury. In cases of
renal infarction, heterogeneity and hypoperfusion
of the renal parenchyma and wedge-shaped areas
of decreased perfusion and/or enhancement may
be visualized at US and contrast-enhanced CT and
may be multifocal, involving both kidneys (Figs 21,
22) (89). It is important to note that use of contrast material may not be possible if renal function
is impaired, thus making US the first-line imaging
modality of choice in the evaluation of COVID-19
in patients with suspected renal vascular insult. In
addition, US contrast material can be administered
to patients that cannot receive intravenous iodinated contrast material and may help demonstrate
perfusion abnormalities and vascular thrombosis.
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Figure 20. Ovarian vein thrombosis in a
27-year-old woman who presented to the
emergency department with right flank
pain. Reverse transcription–polymerase
chain reaction test results confirmed COVID-19. Coronal contrast-enhanced CT
image of the abdomen and pelvis shows a
long segment filling defect (arrows) in the
left ovarian vein, indicative of gonadal vein
thrombosis. Given the positive COVID-19
results, it is uncertain if the viral infection
was the cause of the thrombosis, as no
other preexisting conditions or risk factors
were identified.

There is medium expression of ACE2 receptors in the urinary bladder, thus offering affinity for SARS-CoV-2 viral binding and cell entry
(90). This process can result in the development
of interstitial cystitis and/or hemorrhagic cystitis,
which is evident at US and CT by diffuse irregularity and wall thickening of the urinary bladder
(Figs 23, 25). Additionally, evidence suggests that
SARS-CoV-2 infection may involve the testes by
targeting epithelial cells of testicular seminiferous
tubules and Leydig cells, resulting in apoptosis
and immune-mediated autoimmune orchitis and
gonadal dysfunction (91).

Spleen and Lymph Nodes
It has been shown that splenic injury is commonly encountered in patients with COVID-19,
as SARS-CoV-2 can directly target macrophages
and dendritic cells in the spleen and lymph nodes.
Additionally, red pulp cells and endothelial cells of
blood vessels demonstrate an abundance of ACE2
receptors on their surfaces, which allow viral particles to enter and cause direct damage (65). Splenic
parenchymal congestion, hemorrhage, and a lack
of lymphoid follicles were all evident at autopsy in
patients who died from COVID-19, in addition
to splenic parenchymal atrophy (as evidenced by
the presence of fibrous tissue hyperplasia within

Figure 21. Renal infarcts in a 57-year-old man
with COVID-19, diagnosed after presenting to the
emergency department with abdominal pain. Coronal contrast-enhanced CT image of the abdomen
and pelvis shows multiple linear hypoattenuating
areas, extending from the left renal sinus to the surface of the cortex (white arrows). Note the occlusive
thrombus (black arrow) in the segmental left renal
artery. The findings are indicative of an infarct of the
left kidney. Small wedge-shaped regions of hypoattenuation were also present in the right kidney, indicative of an infarct (not shown). Note the small
amount of perihepatic free fluid (FF).

Figure 22. Renal infarct in a critically ill 52-yearold man who underwent intubation for COVID-19
and who presented with oliguria and was diagnosed
with elevated creatinine levels. Sagittal color Doppler US image shows a focal area of hypoperfusion
(solid arrows) in the upper pole of the left kidney, compatible with an infarct. Normal perfusion
(dashed arrows) is seen in the lower pole of the kidney. Bilateral patchy ground-glass opacities, a typical
finding of COVID-19 pneumonia, were depicted at
chest radiography (not shown).

splenic sinuses) (92). Splenic atrophy has been
associated with significant lymphocytopenia, as
well as macrophage proliferation and macrophage
phagocytosis. Lymphocytopenia results from
virally mediated lymphocyte apoptosis by activation of T and B cells within the spleen and lymph
nodes. Thus, SARS-CoV-2 infection may cause
impairment of the immune system by severe damage to the spleen and lymph nodes (92).

RG • Volume 40 Number 7

Revzin et al

1883

Figure 23. Splenic infarcts and cystitis in an 84-year-old man with a history of newly diagnosed lung cancer who presented to the
emergency department with left upper quadrant pain and urinary frequency. The test results confirmed COVID-19. (a, b) Coronal (a)
and axial (b) contrast-enhanced CT images of the abdomen and pelvis show multiple wedge-shaped areas of hypoattenuation in the
spleen (solid white arrows in a), indicative of multifocal splenic infarcts. Associated thrombosis of one of the splenic hilar branches supplying the anterior upper pole of the spleen is noted (dashed arrow in a). In addition, there is marked irregular wall thickening of the contrast material–filled urinary bladder (B and black arrows in a and b). It is important to note that patients with underlying conditions (such
as hypercoagulable state in the setting of malignancy) are prone to develop complications of COVID-19. (c) Axial diffusion-weighted
image (DWI) of the brain obtained during a hospital stay for newly developed neurological deficits shows a confluent region of restricted
diffusion (arrows) within territory supplied by the left middle cerebral artery, indicative of an acute infarct. A long segment thrombus in
the left middle cerebral artery was detected (not shown).

Figure 24. Pancreatitis and enteritis in a 56-year-old woman with COVID-19.
Axial (a) and coronal (b) CT images of the abdomen and pelvis obtained with
oral (no intravenous) contrast material shows a heterogeneous edematous pancreas with associated inflammatory changes and small amount of peripancreatic
fluid (solid arrows), indicative of pancreatitis. Note the nondistended loops of
small bowel that show mild wall thickening (dashed arrows in b) and mesenteric
inflammation (* in b) that, although they are nonspecific in the setting of pancreatitis, may be indicative of enteritis.

To date, only a few imaging findings of splenic
injuries related to COVID-19 have been reported,
including splenomegaly and the development
of either solitary or multifocal splenic infarcts,
evidenced by wedge-shaped areas of heterogeneity
and lack of splenic parenchymal perfusion (Fig 23)
(93). Splenic infarct is attributable to microangiopathy or systemic hypercoagulopathy and cardiothromboembolization. The prevalence of splenic
infarctions is likely underestimated, as abdominal
imaging is not routinely performed owing to insufficient clinical symptoms associated with splenic
infarcts, as well as general limitations of imaging
in the COVID-19 population. Splenic infarcts are
often diagnosed incidentally at chest CT examinations that extend to the upper abdomen (93).

Musculoskeletal Manifestations

To date, no significant musculoskeletal manifestations of COVID-19 have been reported, although
a few case reports in the literature report the
development of rhabdomyolysis as a potential late
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Figure 25.
Urinary bladder hemorrhage in an
85-year-old man with COVID-19 pneumonia who developed hematuria and acute renal failure. Transverse
gray-scale (left) and color Doppler (right) US images
show a distended urinary bladder (B) filled with avascular heterogeneous echogenic material, indicative of
urinary bladder hemorrhage (arrows).

complication of COVID-19 (94,95). Rhabdomyolysis is a life-threatening disorder that manifests
with myalgia, fatigue, and pigmenturia (owing to
high levels of myoglobin). Often, rhabdomyolysis
is complicated by the development of acute renal
failure, and the results of laboratory tests show
markedly elevated levels of serum creatine kinase,
with values ranging from 1500 to over 100 000
international units/L (96,97). Although mostly a
clinical diagnosis, imaging findings of rhabdomyolysis include enlargement of the affected muscle or
muscle group, which demonstrates heterogeneous
hypoattenuation at CT (when compared with that
of intact muscles) and occasional rim enhancement on postcontrast images (Fig 26).
Although not required for evaluation, MRI
findings may support the diagnosis and assist in
the delineation of the extent and severity of muscle
injury (98). There are two types of disease recognized. Type 1 is characterized by homogeneously
hyperintense signal with T2-weighted and short-τ
inversion-recovery (STIR) sequences and demonstrates homogeneous enhancement following
contrast material administration. Type 2 usually
demonstrates heterogeneously hyperintense signal
on T2-weighted images and rim enhancement following contrast material administration (99). When
disease is severe, features of myonecrosis may also
be present, with heterogeneous muscle parenchyma with rim enhancement and possible areas of
necrosis visualized as T2-hyperintense areas when
compared with the adjacent intact muscle signal
intensity. The stipple sign, represented by enhancing foci within a region of otherwise nonenhanced
muscle tissue surrounded by rim enhancement, is
a hallmark of myonecrosis (98). Prompt clinical
recognition and treatment of dehydration in COVID-19–associated rhabdomyolysis can reduce the
risk of serious adverse outcomes (95).

Dermatologic and Ocular
Manifestations
Dermatologic Manifestations
There are a number of known cutaneous manifestations of COVID-19, including acral areas

of erythema with vesicles or pustules (pseudochilblain, similar in appearance to frostbite, also
known as COVID toes) (19%), other vesicular
eruptions (9%), urticarial lesions (19%), maculopapular eruptions (47%), and livedo reticularis or
necrosis (6%), owing to a generalized microvascular thrombotic disorder (100). Vesicular eruptions appear early in the course of COVID-19,
while the pseudochilblain pattern frequently
appears late in the evolution of the disease (Fig
E6) (101). The other manifestations occur in a
more sporadic fashion (102). The dermatologic
manifestations seem to correlate with the severity
of disease, with acral lesions found in cases of less
severe disease and the latter manifestations seen
in more severe cases (Fig E7) (101,103).
Recognizing typical appearances of some skin
manifestations (especially COVID toes) in the
setting of a pending diagnosis may help radiologists and radiology staff members increase awareness that a patient undergoing imaging may have
COVID-19. This would ensure proper implementation of protective practices when imaging this
group, as well as increase the radiologist’s awareness of other potential manifestations.

Ocular Manifestations
Several ocular manifestations of COVID-19
infection have been recognized: epiphora, conjunctival congestion, and chemosis (104). It is
helpful for radiologists and radiology staff to
recognize ocular manifestations of COVID-19
while performing imaging examinations, as this
can increase awareness of potential COVID-19
in patients who may otherwise exhibit few or no
symptoms.

Pediatric Manifestations

In the United States and globally, there have been
fewer cases of COVID-19 reported in children
(ages 0–17) than in adults (105). Taking into
account that children comprise 22% of the U.S.
population, as of August 3, 2020, data have shown
that 7.3% of all cases of COVID-19 reported to
the Centers for Disease Control and Prevention
were in children (36,106). However, between
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Figure 26. Rhabdomyolysis in a 34-year-old man who presented with minor trauma and was diagnosed with COVID-19 in the emergency department. Laboratory analysis results demonstrated an extremely high creatine kinase level of 35 145 U/L (normal range, 39–308 U/L). (a–c) Coronal (a) and axial
(b, c) contrast-enhanced CT images of the pelvis show an enlarged right gluteal region (arrows) without
associated fracture. (d–f) Axial (d) and coronal (e) contrast-enhanced chest CT images and a CT image
with an artificial intelligence deep learning algorithm for the detection of pulmonary embolism (f) show
bilateral multifocal multilobar peribronchovascular patchy airspace and ground-glass opacities (arrows
in d), which are a typical finding for COVID-19. Multiple segmental and subsegmental right lower lobe
pulmonary emboli (arrows in e and f) were also detected.

March 2020 and July 2020, there has been a
steady increase in the number and rate of COVID-19 cases in children in the United States, and
it is also important to note that the true incidence
of SARS-CoV-2 infection in children remains
unknown owing to testing-related selection bias
(lack of widespread testing and the prioritization
of testing for adults and those with severe illness).
Data regarding the epidemiologic characteristics,
transmission rates, and clinical features of pediatric infections remain limited (36,59).
According to data derived from a number of
hospitalization rates in children, pediatric CO-

VID-19 cases have relatively milder symptoms
and less severe illness in general when compared
with those of older patients (107). The reason
for this difference between children and adults
remains elusive, although there are reports that
suggest that children may have lower viral loads
(108). Most children who required intensive care
support had preexisting conditions (36), and in
the United States, infants accounted for the highest percentage of hospitalizations (15%–62%).
Whereas 18.5% of adults with COVID-19 had
severe disease, only 6% of children with COVID-19 exhibited severe symptoms (109).
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Figure 27.
Hypoxic ischemic encephalopathy in a
2-day-old full-term newborn boy who was born by cesarean delivery in a 32-year-old woman with COVID-19.
Coagulopathy was diagnosed at birth, with an elevated
international normalized ratio of 2.0. The infant died on
day 2 following birth. Sagittal gray-scale US images of the
neonatal brain obtained at the level of the right (a) and
left (b) thalami (T) show increased echogenicity within
the thalami (arrows), compatible with hypoxic ischemic
encephalopathy. The adjacent midline structures are intact, and no germinal matrix or intraventricular hemorrhage was visualized. The lateral ventricles were normal
in size. No parenchymal mass, hematoma, or extra-axial
fluid collections were depicted.

Evidence suggests that as many as 45%
of pediatric patients are asymptomatic (110),
although when symptomatic, the most common manifestations are fever (95%) and cough
(86%) (111). A recent multicenter multinational
cohort study in Europe reported that up to 54%
of symptomatic children and adolescents present
with symptoms of upper respiratory tract infection, such as pharyngitis, tonsillitis, otitis media,
or sinusitis (112).
Despite the tendency toward favorable outcomes in the pediatric population, a number of
pediatric COVID-19 deaths have been reported
in the United States and in other countries (111).
Immunocompromised children and those with
respiratory and/or cardiac disease comprise the
largest subsets of underlying medical conditions
in children with COVID-19. Coinfections are observed in 5.6% of children (111), and the mean
age of presentation in the pediatric population is
8.9 years. Over three-fourths of patients (75.6%)
had a history of exposure to a family member
who had been diagnosed with COVID-19 or had
been residing in an area with a high population of
cases, both of which serve as the most common
vectors for childhood infection (111).
Although chest radiography is frequently the
first imaging study performed in a pediatric patient presenting with fever, cough, and/or shortness of breath, current literature describing COVID-19 findings on chest radiographs in children
is relatively scarce. In a systematic review article
published in Lancet, Hoang et al (111) reported
that most patients had normal chest radiographs.
At CT, diffuse bilateral ground-glass opacities
were the most common finding at all stages of
disease (36,113), and a peripheral distribution
of pulmonary opacities was observed, similar to
in adult patients. However, it is interesting to
note that consolidations with a surrounding halo
sign were more commonly visualized in children
than adults (113), and that no associated lymph-

adenopathy or pleural effusions were observed
(113). According to the American College of
Radiology Appropriateness Criteria, imaging is
not indicated in a well-appearing immunocompetent child older than 3 months of age who does
not require hospitalization. However, if the child
is not responding to outpatient management or
requires hospitalization, chest radiography is considered the most appropriate first step in imaging
evaluation (114). Similar to the adult population, the Radiological Society of North America
consensus statement on pediatric patients with
respect to use of CT states that chest CT should
be reserved for symptomatic hospitalized patients
with specific clinical indications (115). Given
its relative safety and repeatability, lung US is
another imaging modality that has been widely
used in pediatric patients with COVID-19, with
similar findings in the lungs with those in the
adult population (5).
There are limited data regarding the neurologic manifestations of COVID-19 in children.
At our institutions, there was a single case of
a thalamic hemorrhage diagnosed in an infant
who was born to a COVID-19–positive mother.
Intracranial US demonstrated a geographic area
of increased echogenicity in the cerebral parenchyma at the level of bilateral thalami (Fig 27). If
necessary, contrast-enhanced CT of the neck can
be performed in patients presenting with upper
respiratory symptoms, including those of tonsillitis, otitis, and sinusitis, to evaluate for potential
complications such as abscess formation (Fig 28).
In late April 2020, the National Health Service in the United Kingdom issued an alert to
pediatricians about an unprecedented cluster
of children who presented with symptoms of
hyperinflammatory shock, with features similar to
those of atypical Kawasaki disease, Kawasaki disease shock syndrome, or toxic shock syndrome.
All children either received positive test results
for COVID-19, had antibodies to the infection,
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Figure 28. Tonsillitis in a 15-year-old boy who
presented to the emergency department with fever, sore throat, malaise, and right neck swelling
and was diagnosed with elevated d-dimer levels
and inflammatory marker levels. The test results
were positive for COVID-19. (a–c) Axial (a)
and coronal (b, c) contrast-enhanced neck CT
images show enlarged palatine tonsils (black arrows in a and arrows in b). A subtle ill-defined
asymmetric area of hypoattenuation is depicted
within the enlarged left palatine tonsil, consistent
with phlegmon or early abscess (white arrow in
a). Associated cervical lymphadenopathy (arrows
in c) is depicted. (d) Sagittal power Doppler US
image of the right superior neck shows a nearcomplete occlusive thrombus (arrows) in the
right jugular vein (RT IJV).

or had been exposed to patients with COVID-19
(116). Similar case reports also emerged throughout Europe and the United States, specifically in
New York.
Clinical presentation included fever (38°–
40°C), variable rash, conjunctivitis, peripheral
edema, generalized extremity pain, and significant gastrointestinal symptoms (117–119).
This presentation is currently termed pediatric
multisystem inflammatory syndrome (PMIS)
(116,120–122) and is thought to be caused by
an autoimmune-mediated systemic response of
autoantibodies to the virus. The SARS-CoV-2 antibody itself is likely responsible for provoking the
immune response (116). Children who exhibit
symptoms of PMIS may present with abdominal
pain, vomiting, and diarrhea, and a proportion
may present with acute heart failure and features
of acute myocarditis (122).
Based on a recently published case series of 35
children who developed post–COVID-19 PMIS,
a pattern of imaging abnormalities was described
and included airway inflammation, rapidly progressive pulmonary edema, coronary artery
aneurysms, and extensive abdominal inflammatory
changes within the right iliac fossa, with lymphadenopathy and bowel wall thickening (119). In
this series, 46% of chest radiographs were normal,
and the findings on abnormal chest radiographs
consisted of peribronchial cuffing and perihilar
interstitial thickening (34%), which rapidly progressed to perihilar airspace opacification. Bilateral

pleural effusions were seen in 14% of patients, and
atelectasis (predominately involving the left lower
lobe) was found in 20% of patients. Additionally, in this case series, 30%–40% patients who
underwent chest CT had predominately bibasilar
consolidations, with lung collapse and pleural effusions. Diffuse bilateral ground-glass opacification
in combination with patchy dense consolidation
was only seen in 9% (119).
In patients with PMIS, signs of cardiac
dysfunction were seen in 51% of children, with
abnormal echocardiographic findings depicting
deteriorating myocardial function, myocarditis,
pancarditis, dilated cardiomyopathy, pericardial effusions, and coronary artery aneurysms.
Coronary artery aneurysms were best detected
either at echocardiography or cardiac CT, with
abnormalities ranging from mild single artery
dilatation to large aneurysms affecting more than
one coronary artery, with sizes ranging from 4 to
7.7 mm in diameter (119) (Fig 29, Movies 2,3).
Myocarditis-related imaging findings are discussed in the previous cardiac section.
In children with PMIS, a wide spectrum of
abdominal abnormalities can manifest that can be
detected at both abdominal US and CT, with periportal and pericholecystic edema, gallbladder wall
and bowel wall thickening and dilatation, splenic
infarcts, hepatosplenomegaly, right lower quadrant
mesenteric lymphadenopathy, and free fluid in the
pelvis being among the most commonly encountered abnormalities (119). It is important to note
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Figure 29. Coronary artery dilatation and decreased ventricular ejection fraction in a 9-year-old boy
with a recent history of COVID-19 who presented with new onset of hypotension, kidney disease, and
elevated troponin and d-dimer levels (same patient as in Movies 2 and 3). Parasternal short-axis echocardiograms show lack of tapering in the left anterior descending (LAD) coronary artery (arrows in a) and the
right coronary artery (RCA) (arrows in b). Left ventricular ejection fraction was decreased (not shown). Ao =
aorta, L MCA = left main coronary artery. (Case courtesy of Misra Nilanjana, MD, Northwell Health, New
Hyde Park, NY.)

that, on the basis of the scarcity of reported data
on PMIS, caution must be taken when generalizing the results of a few reported studies to an
entire population.

COVID-19 in Pregnancy

It is not currently known if pregnant patients
have a higher risk of contracting COVID-19
when compared with the general population or
whether they are more likely to have serious complications as a result of COVID-19 (123,124).
Based on available information, it appears that
pregnant patients have the same risk of contracting the infection as adults of similar age who are
not pregnant. However, it is hypothesized that,
owing to alterations in physiology associated with
pregnancy, these patients may have an increased
risk of infections in general.
In addition, a case-controlled study performed in 2014 in pregnant patients with
SARS-CoV infection demonstrated that, when
infected, pregnant women have a higher risk
of developing severe illness (125). However, a
recent study of 43 pregnant women showed that
disease severity in this small cohort appeared to
be similar (86% mild, 9.3% severe, and 4.7%
critical) to that described in the literature in
nonpregnant patients (126). It was also found
that pregnancy and delivery did not aggravate
the severity of COVID-19 pneumonia (127).
Pregnancy complicated by ARDS that resulted
in preterm delivery of a fetus has also been described (128). It has therefore been advised that
pregnant women avoid exposure to the virus and
practice self-hygiene and social distancing. It is
important to note that the effects of the virus
early in pregnancy are unknown, as no known

live infants have been delivered by women
infected in the first and second trimesters of
pregnancy at this time.
Mother-to-fetus (vertical) transmission of
coronavirus during pregnancy is currently a controversial topic. Breslin et al (126) and Chen et
al (129) reported that there was no evidence for
intrauterine infection caused by vertical transmission in women who develop COVID-19 pneumonia late in pregnancy. On the contrary, Pentfield
et al (130) found the presence of viral RNA by
the results of reverse transcription–polymerase
chain reaction tests of placental membranes at
the time of delivery, which suggests the need
for further research into the possibility of vertical transmission. There is also a case report that
describes second-trimester pregnancy resulting
in miscarriage owing to COVID-19 (131). In this
study, the maternal portion of the placenta tested
positive for virus particles.
After birth, a newborn may be susceptible to
person-to-person transmission of COVID-19. In
the current literature, a small number of newborn
infants have tested positive for the virus. However, it is unknown if the infants contracted the
virus before or after birth. In a limited number of
studies published to date, COVID-19 virus has
not been detected in amniotic fluid, cord blood,
neonatal throat swab specimens, or breast milk
(129). Although preliminary data suggest that
children are much less affected by COVID-19
than their adult counterparts, the level of risk to
newborns is largely unknown (132).
Pregnant patients with COVID-19 with mild
and moderate respiratory symptoms who undergo chest radiography and chest CT show
typical findings of pulmonary disease, character-
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ized by multifocal patchy bilateral ground-glass
opacities, with crazy-paving patterns and consolidations found with disease progression. Lymphadenopathy and pleural effusions are rarely
depicted (127,129,133). ARDS-related imaging
findings have also been readily detected (128).
Pulmonary CT angiography should be performed
in pregnant patients with suspected pulmonary
embolism. It is important to note that while
performing CT in pregnant patients, it is preferable to use a low-radiation-dose imaging mode to
decrease the risk of maternal and fetal radiation
exposure, and whenever possible the abdomen
and pelvis should be covered by a lead blanket.
In general, US is the preferred modality for the
evaluation of a pregnant patient and the fetus,
as it can be used for evaluation and surveillance
of the maternal lungs, assessment of potential
maternal abdominal and vascular complications,
and evaluation of fetal well-being, as well as the
gravid uterus.

Conclusion

SARS-CoV-2 is a novel coronavirus that has
rapidly resulted in a worldwide pandemic and has
been the cause of extreme morbidity and mortality. It primarily affects the respiratory system but
has also been shown to impact other systems in
the human body, resulting in multiorgan injury
and, in some cases, failure. Imaging plays a significant role in the detection, diagnosis, and assessment of virus-induced injury and associated complications. Recognizing and understanding the
pathophysiology of the virus and its effects on the
immune system and coagulation is paramount
toward improving radiologists’ ability to accurately identify key imaging findings and promptly
recognize possible complications, thus minimizing the number of diagnostic misinterpretations.
Owing to the complexity of viral pathophysiology
and its targeting of multiple organ systems, the
recognition of one complication should prompt
intense scrutiny for others, particularly if patients are critically ill. A thorough knowledge of
diagnostic imaging hallmarks, atypical imaging
features, multisystem manifestations, and evolution of imaging findings is essential to optimize
patient care.
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